EGFR and neoplasm: Akbay et al. 77showed that in murine lung tumor cells there is upregulation of tumor PD-L1 via mutant EGFR signaling, and that in preclinical models there was a survival benefit when therapeutic blockade of the PD-L1 pathway was attempted.